Immix Biopharma
IPOHome - IMMIX BIOPHARMA INC
Public · Los Angeles, United States · Founded 2017 · $9.1M raised
- Headquarters
- Los Angeles, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- immixbio.com
- Total Funding
- $9.1M
- Last Round
- $9.1M Series CSep 2025
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company pioneering cell therapies for AL Amyloidosis and other serious diseases.
Summary
Immix Biopharma is a Biotech company based in Los Angeles, United States, founded in 2017. It has raised $9.1M in total across 1 round, most recently a $9.1M Series C round in Sep 2025. Investors include Morgan Stanley and Goose Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...